In another study, Tian et al. demonstrated that miR-361-5p attenuates chemotherapy resistance in gastric cancer cells by targeting forkhead box protein M1 (FOXM1) and activating the PI3K/Akt signaling pathway [12]. The gene discussed is FOXM1; the disease is gastric cancer.